Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alx, Annexin, Aptose, Aqilion, Bio-Thera, CNS, EIP, Eloxx, Ketabon, Longeveron, Lytix, Medivir, Moleculin, Plus, SFA, Taysha, Telix, Verrica.